The    international    community    sits    at    the    tipping    pointof    a    post-‐antibiotic    era,    where    common     bacterial     infections     are     no     longer     treatable     with     the     antibiotic    armamentarium    that    exists.    In    South    Africa,    t...he    identification    of    the    first    case    of    pan-‐resistant    Klebsiella     pneumoniae(Brink     et     al,     J     Clin     Microbiol. 2013;51(1):369-‐72)    marks     a     watershed     moment     and     highlights    ourtip     of     the     antibiotic     resistance    ‘iceberg’      in      this      country.      Multi-‐drug      resistant      (MDR)-‐bacterial      infections,    predominantly    in    Gram-‐negative    bacteria    such    as    Klebsiella    pneumoniae,    Escherichia    coli,    Pseudomonas     aeruginosaand    Acinetobacter     baumanniiare    now    commonplace    in    South    African    hospitals.    Whilst    a    number    of    expensive    new    antibiotics    for    Gram-‐positive     bacterial     infections     have     been     manufactured     recently     (some     of     which     are    licenced     for     usein     South     Africa),     no     new     antibiotics     active     against     Gram-‐negative    infections    are    expected    in    the    next    10-‐15years.    Hence    what    we    have    now,    needs    conserving
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Rediscovering Biology
Molecular to Global Perspectives
Accessed: 03.09.2019
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                These new reports from WHO document evidence of widespread inappropriate promotion of baby and toddler foods. Despite the WHO Guidance on ending inappropriate promotion of foods for infants and young children agreed in 2016 and nearly 40 years since the introduction of the International Code of Mark...eting of Breast-milk Substitutes, many companies that manufacture or distribute commercial baby foods fail to comply with these rules.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The  global  COVID-19  outbreak  is  leading  to  an  acute  and  drastic  shortage  of  essential  supplies,  including  personal protective equipment, diagnostics and clinical management. At the request of the UN Secretary-General and in support of the UN Crisis Management Team, a Supply Chain Tas...k Force has been convened to establish the COVID-19 Supply Chain System (CSCS).
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Mission report April 2016
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The Integrated Management of Adolescent/Adult Illness (IMAI) approach
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                WHO has developed this manual in order to strengthen the laboratory diagnosis and virological surveillance of influenza infection.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts) 
Number: PQDx 0133-045-00
0133-045-00 WHO 
PQDx PR 
June/2016, version 2.0
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Historically,  the  discovery  of  the  sulfa  drugs  in  the 1930s   and   the   subsequent   development   of   penicillin during   World   War   II   ushered   in   a   new   era   in   the treatment  of  infectious  diseases.  Infections  that  were common causes of death and disease in the pre-...antibiotic era  -  rheumatic  fever,  syphilis,  cellulitis  and  bacterial pneumonia - became treatable, and over the next 20 years most  of  the  classes  of  antibiotics  that  find  clinical  use today   were   discovered   and   changed   medicine   in   a profound   way.   The   availability   of   antibiotics   enabled revolutionary   medical   interventions   such   as   cancer chemotherapy, organ transplants and essentially all major invasive  surgeries  from  joint  replacements  to  coronary bypass.  Antibiotics,  though,  are  unique  among  drugs  in that  their  use  precipitates  their  obsolescence.  Paradoxically,  these  cures  select  for  organisms  that  can  evade them,  fueling  an  arms  race  between  microbes,  clinicians and drug discoverers.
Wright BMC Biology 2010, 8:123 http://www.biomedcentral.com/1741-7007/8/12
                                                                    more